APEN实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 Apr 2023 @ 04:00):

Stats
今日成交量	1.64M
平均成交量	1.33M
市值	579.72M
EPS	$0 ( 2024-03-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.43
ATR14	$0.0390 (0.39%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-04	Mcgaughy R Kent Jr	Sell	400 675	Common Stock
2023-04-04	Mcgaughy R Kent Jr	Sell	38 667	Stock Option (Right to Buy)
2023-04-04	Cpmg Inc	Sell	400 675	Common Stock
2023-04-04	Barr John R	Sell	44 082	Common Stock
2023-04-04	Barr John R	Sell	5 271	Non-Qualified Stock Option (right to buy)

INSIDER POWER
-16.45
Last 98 transactions
Buy: 5 638 377 \| Sell: 4 907 735

音量相关性

長: 0.13 (neutral)

短: 0.00 (neutral)

Signal:(66.037) Neutral

Apollo Endosurgery Inc 相关性

10 最正相关
NETE	0.955
MDGL	0.952
RAVN	0.922
SRAC	0.9
UFPT	0.886
AGYS	0.883
NRIM	0.882
PODD	0.879
TSBK	0.879
AMRB	0.875

10 最负相关
BVXV	-0.948
SNPX	-0.938
SVAC	-0.935
FREQ	-0.934
PAIC	-0.933
SVOK	-0.928
TSP	-0.923
ALTM	-0.922
ZI	-0.919
SGRP	-0.917

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Apollo Endosurgery Inc 相关性 - 货币/商品

0.33
( neutral )

0.47
( neutral )

-0.30
( neutral )

0.41
( neutral )

-0.29
( neutral )

Apollo Endosurgery Inc 财务报表

Annual	2022
营收:	$76.86M
毛利润:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2022
营收:	$76.86M
毛利润:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2021
营收:	$62.99M
毛利润:	$34.96M (55.50 %)
EPS:	$-0.820

FY	2020
营收:	$42.05M
毛利润:	$22.24M (52.90 %)
EPS:	$-0.990

Financial Reports:

No articles found.

Apollo Endosurgery Inc

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.